NANOVIRICIDES, INC.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2021 | — | $29.9M | $20.5M |
| FY2022 | — | $23.1M | $14.1M |
| FY2023 | — | $14.9M | $8.1M |
| FY2024 | — | $11.5M | $4.8M |
| FY2025 | — | $7.5M | $1.6M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2021 | — | $29.9M | $20.5M |
| FY2022 | — | $23.1M | $14.1M |
| FY2023 | — | $14.9M | $8.1M |
| FY2024 | — | $11.5M | $4.8M |
| FY2025 | — | $7.5M | $1.6M |